Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease

The primary objective of this study was to evaluate how schizophrenia (SCH) spectrum disorders and applied antipsychotic (AP) treatment affect serum level of amino acids (AAs) and biogenic amines (BAs) in the early course of the disorder. We measured 21 different AAs and 10 BAs in a sample of antips...

Descripción completa

Detalles Bibliográficos
Autores principales: Parksepp, Madis, Leppik, Liisa, Koch, Kadri, Uppin, Kärt, Kangro, Raul, Haring, Liina, Vasar, Eero, Zilmer, Mihkel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438522/
https://www.ncbi.nlm.nih.gov/pubmed/32814830
http://dx.doi.org/10.1038/s41598-020-71014-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438522/
https://www.ncbi.nlm.nih.gov/pubmed/32814830
http://dx.doi.org/10.1038/s41598-020-71014-w

Ejemplares similares